Search clinical trials for: Glucagon-like peptide-1
Total 752 results
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo...Not yet recruitingObesity | Diabetes type1United States
-
Capital Medical UniversityNot yet recruitingIdiopathic Intracranial Hypertension
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Vanderbilt University Medical CenterRecruitingType 1 DiabetesUnited States
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Ukraine, Morocco, Belgium, Czechia, Taiw...
-
Novo Nordisk A/SCompletedHealthy ParticipantsUnited States, Canada
-
Boehringer IngelheimNot yet recruiting
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)Active, not recruiting
-
Novo Nordisk A/SCompleted
-
Massachusetts General HospitalBoston UniversityTerminatedDiabetes Mellitus Type 1United States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingType 2 Diabetes MellitusChina
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, India, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
Odense University HospitalRecruitingType 2 Diabetes | OsteopeniaDenmark
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)RecruitingDiabetes Mellitus, Type 1United States
-
Jan FrystykRegion of Southern Denmark; Region Zealand; Steno Diabetes Center Sjaelland; Steno...RecruitingSchizophrenia | Prediabetic StateDenmark
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eli Lilly and CompanyCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease | Type 2 Diabetes Mellitus (T2DM) | Hypoglycemic AgentsJapan
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Germany, United Kingdom
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
University of WashingtonNovo Nordisk A/SRecruitingDiabetes Mellitus, Type 2 | Stroke (CVA) or Transient Ischemic AttackUnited States
-
University of HullNot yet recruitingPolycystic Ovary SyndromeUnited Kingdom
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Novo Nordisk A/SRecruiting
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
Papworth Hospital NHS Foundation TrustUnknownMyocardial Infarction | Angina Pectoris | Coronary Heart Disease | Reperfusion InjuryUnited Kingdom
-
Johns Hopkins UniversityTerminated
-
Christina KruuseRecruitingIschemic StrokeDenmark
-
Centre Hospitalier Universitaire de NiceRecruiting
-
University of CopenhagenHvidovre University HospitalRecruitingSpinal Cord InjuriesDenmark
-
GlyPharma TherapeuticsVectivBio AGCompletedShort Bowel SyndromeDenmark
-
Klaus Gottlob MüllerNovo Nordisk A/S; Independent Research Fund DenmarkNot yet recruitingInflammation | Chemotherapeutic Toxicity | Intestinal Mucositis
-
Umm Al-Qura UniversityRecruitingRheumatoid Arthritis RASaudi Arabia
-
Janssen Research & Development, LLCCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
University of OxfordNovo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United Kingdom
-
Jaeb Center for Health ResearchXeris PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States
-
Jaeb Center for Health ResearchXeris PharmaceuticalsCompleted
-
Steno Diabetes Center CopenhagenUnknownEffect of Glucagon-like Peptide 2 on Gallbladder MotilityDenmark
-
Jens D Hove, MD,PHDRecruitingObesity | Weight Loss | Chronic Heart Failure | Heart Failure With Reduced Ejection FractionDenmark
-
Mayo ClinicUnited States Department of DefenseRecruitingObesity | Cardiomyopathy | Heart Failure With Preserved Ejection Fraction (HFpEF)United States
-
Athenex, Inc.CompletedAdvance MalignanciesUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
GlaxoSmithKlineCompleted
-
Wuhan Union Hospital, ChinaPeking University First HospitalRecruitingCardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Type 2China
-
GlaxoSmithKlinePPDWithdrawn
-
First Affiliated Hospital of Zhejiang UniversityRecruitingObesity | Bipolar Disorder | CognitionChina
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingMetabolic Diseases | Type 2 Diabetes | Genetic PredispositionUnited States
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States
-
University of CopenhagenHvidovre University HospitalCompleted
-
University of Sao Paulo General HospitalRecruitingType 2 Diabetes Mellitus in Obese | Severe ObesityBrazil